These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23754790)

  • 1. Water-soluble nitric-oxide-releasing acetylsalicylic acid (ASA) prodrugs.
    Rolando B; Lazzarato L; Donnola M; Marini E; Joseph S; Morini G; Pozzoli C; Fruttero R; Gasco A
    ChemMedChem; 2013 Jul; 8(7):1199-209. PubMed ID: 23754790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Searching for new NO-donor aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid.
    Lazzarato L; Donnola M; Rolando B; Marini E; Cena C; Coruzzi G; Guaita E; Morini G; Fruttero R; Gasco A; Biondi S; Ongini E
    J Med Chem; 2008 Mar; 51(6):1894-903. PubMed ID: 18293898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Searching for new NO-donor aspirin-like molecules: Furoxanylacyl derivatives of salicylic acid and related furazans.
    Lazzarato L; Cena C; Rolando B; Marini E; Lolli ML; Guglielmo S; Guaita E; Morini G; Coruzzi G; Fruttero R; Gasco A
    Bioorg Med Chem; 2011 Oct; 19(19):5852-60. PubMed ID: 21906954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New nitric oxide or hydrogen sulfide releasing aspirins.
    Lazzarato L; Chegaev K; Marini E; Rolando B; Borretto E; Guglielmo S; Joseph S; Di Stilo A; Fruttero R; Gasco A
    J Med Chem; 2011 Aug; 54(15):5478-84. PubMed ID: 21688846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
    Velázquez C; Praveen Rao PN; Knaus EE
    J Med Chem; 2005 Jun; 48(12):4061-7. PubMed ID: 15943479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-generation aspirin and indomethacin prodrugs possessing an O(2)-(acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
    Velázquez CA; Chen QH; Citro ML; Keefer LK; Knaus EE
    J Med Chem; 2008 Mar; 51(6):1954-61. PubMed ID: 18314945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiinflammatory, gastrosparing, and antiplatelet properties of new NO-donor esters of aspirin.
    Cena C; Lolli ML; Lazzarato L; Guaita E; Morini G; Coruzzi G; McElroy SP; Megson IL; Fruttero R; Gasco A
    J Med Chem; 2003 Feb; 46(5):747-54. PubMed ID: 12593655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NO-NSAIDs: Gastric-sparing nitric oxide-releasable prodrugs of non-steroidal anti-inflammatory drugs.
    Nemmani KV; Mali SV; Borhade N; Pathan AR; Karwa M; Pamidiboina V; Senthilkumar SP; Gund M; Jain AK; Mangu NK; Dubash NP; Desai DC; Sharma S; Satyam A
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5297-301. PubMed ID: 19683923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (NONO-ASA) as safe anti-inflammatory, analgesic, antipyretic, antioxidant prodrugs.
    Chattopadhyay M; Velazquez CA; Pruski A; Nia KV; Abdellatif KR; Keefer LK; Kashfi K
    J Pharmacol Exp Ther; 2010 Nov; 335(2):443-50. PubMed ID: 20679133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric-sparing nitric oxide-releasable 'true' prodrugs of aspirin and naproxen.
    Gund M; Gaikwad P; Borhade N; Burhan A; Desai DC; Sharma A; Dhiman M; Patil M; Sheikh J; Thakre G; Tipparam SG; Sharma S; Nemmani KVS; Satyam A
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5587-5592. PubMed ID: 25466180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the in vivo anti-inflammatory and analgesic activity of a highly water-soluble aspirin conjugate.
    Jacob JN; Badyal DK; Bala S
    Basic Clin Pharmacol Toxicol; 2013 Mar; 112(3):171-4. PubMed ID: 22963282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of aggregation inhibition by aspirin and nitrate-aspirin prodrugs in human platelets.
    Harmon S; Inkielewicz-Stepniak I; Jones M; Ledwidge M; Santos-Martinez MJ; Medina C; Radomski MW; Gilmer JF
    J Pharm Pharmacol; 2012 Jan; 64(1):77-89. PubMed ID: 22150675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dinitroglyceryl and diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of aspirin, indomethacin and ibuprofen: synthesis, biological evaluation and nitric oxide release studies.
    Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez CA; Suresh MR; Knaus EE
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3014-8. PubMed ID: 19419861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diazen-1-ium-1,2-diolated and nitrooxyethyl nitric oxide donor ester prodrugs of anti-inflammatory (E)-2-(aryl)-3-(4-methanesulfonylphenyl)acrylic acids: synthesis, cyclooxygenase inhibition, and nitric oxide release studies.
    Abdellatif KR; Chowdhury MA; Dong Y; Chen QH; Knaus EE
    Bioorg Med Chem; 2008 Mar; 16(6):3302-8. PubMed ID: 18096394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: synthesis, biological evaluation and nitric oxide release studies.
    Abdellatif KR; Chowdhury MA; Dong Y; Velázquez C; Das D; Suresh MR; Knaus EE
    Bioorg Med Chem; 2008 Nov; 16(22):9694-8. PubMed ID: 18930406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
    Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T
    J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties.
    Kashfi K; Chattopadhyay M; Kodela R
    Redox Biol; 2015 Dec; 6():287-296. PubMed ID: 26298203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 1-(4-methanesulfonylphenyl)-5-aryl-1H-pyrazol-3-carboxylic acids: synthesis, nitric oxide release studies and anti-inflammatory activities.
    Abdellatif KR; Chowdhury MA; Dong Y; Knaus EE
    Bioorg Med Chem; 2008 Jul; 16(13):6528-34. PubMed ID: 18513975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders.
    Gresele P; Momi S
    Cardiovasc Drug Rev; 2006; 24(2):148-68. PubMed ID: 16961726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins.
    Lazzarato L; Donnola M; Rolando B; Chegaev K; Marini E; Cena C; Di Stilo A; Fruttero R; Biondi S; Ongini E; Gasco A
    J Med Chem; 2009 Aug; 52(16):5058-68. PubMed ID: 20560642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.